The management of recurrent respiratory tract infections in children

European Infectious Disease

Volumn 6, Issue 2, 2012, Pages 111-115

  Schaad, Urs B ^a   Principi, Nicola ^b  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Bacterial infection; Immune response; Immunostimulant; Lung damage; OM 85; Recurrent respiratory tract infections; Virus

Indexed keywords

BACTERIUM LYSATE; BIOSTIM; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IRS 19; LUIVAC; OM 85; OMMUNAL; PAXORAL; PLACEBO; RIBOMUNYL; UNCLASSIFIED DRUG; VAXORAL;

ACUTE OTITIS MEDIA; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; BRONCHITIS; CHILDHOOD DISEASE; DISEASE DURATION; DRUG EFFICACY; DRUG SAFETY; ENVIRONMENTAL FACTOR; FOLLOW UP; GENETIC RISK; HEADACHE; HIGH RISK PATIENT; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN DEFICIENCY; IMMUNOSTIMULATION; MASTOIDITIS; META ANALYSIS (TOPIC); NAUSEA; PARENTING EDUCATION; PNEUMONIA; POSTMARKETING SURVEILLANCE; PROPHYLAXIS; RECURRENT INFECTION; RESPIRATORY TRACT INFECTION; SEPSIS; SINUSITIS; SOCIOECONOMICS; STRATEGIC PLANNING; TREATMENT DURATION; VIRUS INFECTION;

EID: 84875254490     PISSN: 17551137     EISSN: 17551145     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Williams BG, Gouws E, Boschi-Pinto C, et al., Estimates of world-wide distribution of child deaths from acute respiratory infections, Lancet Infect Dis, 2002;2:25-32.
2. Kvaerner KJ, Nafstad P, Jaakkola JJ, Upper respiratory morbidity in preschool children: a cross-sectional study, Arch Otolaryngol Head Neck Surg, 2000;126:1201-6
3. Jokinen C, Heiskanen L, Juvonen H, et al., Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland, Am J Epidemiol, 1993;137:977-88.
4. Rudan I, Boschi-Pinto C, Biloglav Z, et al., Epidemiology and etiology of childhood pneumonia, Bull World Health Organ, 2008;86:408-16.
5. Wardlaw T, Salama P, Johansson EW, Mason E, Pneumonia: the leading killer of children, Lancet, 2006;368:1048-50
6. UNICEF, Pneumonia and diarrhoea: Tackling the deadliest diseases for the world's poorest children, 2012. Available at: www.unicef.org/media/files/UNICEF_P_D_complete_0604.pdf (accessed 2 July 2012).
7. Jesenak M, Ciljakova M, Rennerova Z, et al., Recurrent Respiratory Infections in Children - Definition, Diagnostic Approach, Treatment and Prevention, MartÃn-Loeches I (eds.), Bronchitis (2011), InTech, Available at: www.intechopen.com/books/bronchitis/recurrentrespiratory-infections-in-children-definition-diagnosticapproach-treatment-and-prevention (accessed 23 May 2012).
8. Bellanti JA, Recurrent respiratory tract infections in paediatric patients, Drugs, 1997;54 Suppl 1:1-4
9. Esposito S, Daleno C, Tagliabue C, et al., Impact of rhinoviruses on pediatric community-acquired pneumonia, Eur J Clin Microbiol Infect Dis, 2012;31:1637-45.
10. Thompson WW, Shay DK, Weintraub E, et al., Influenzaassociated hospitalizations in the United States, JAMA, 2004;292:1333-40.
11. Poehling KA, Edwards KM, Weinberg GA, et al., The underrecognized burden of influenza in young children, N Engl J Med, 2006;355:31-40.
12. Kowalska M, Kowalska H, Zawadzka-Glos L, et al., Dysfunction of peripheral blood granulocyte oxidative metabolism in children with recurrent upper respiratory tract infections, Int J Pediatr Otorhinolaryngol, 2003;67:365-71.
13. Salami A, Dellepiane M, Crippa B, et al., Sulphurous water inhalations in the prophylaxis of recurrent upper respiratory tract infections, Int J Pediatr Otorhinolaryngol, 2008;72:1717-22.
14. Brook I, Shah K, Bacteriology of adenoids and tonsils in children with recurrent adenotonsillitis, Ann Otol Rhinol Laryngol, 2001;110:844-8
15. Gehanno P, Panajotopoulos A, Barry B, et al., Microbiology of otitis media in the Paris, France, area from 1987 to 1997, Pediatr Infect Dis J, 2001;20:570-3.
16. Schwerk N, Brinkmann F, Soudah B, et al., Wheeze in preschool age is associated with pulmonary bacterial infection and resolves after antibiotic therapy, PLoS One, 2011;6:e27913.
17. Schaad UB, OM-85 BV, an immunostimulant in pediatric recurrent respiratory tract infections: a systematic review, World J Pediatr, 2010;6:5-12
18. David JR, Rosen FS, Deficiencies in immunoglobulins and cellmediated immunity (CD-Rom). Chapter IX, Scientific American Medicine, New York, US, SAM-CD, 2000.
19. Wheeler JG, Evaluating the child with recurrent infections, Am Fam Physician, 1996;54:2276-82,85-6
20. Wheeler JG, Steiner D, Evaluation of humoral responsiveness in children, Pediatr Infect Dis J, 1992;11:304-10
21. Yang KD, Hill HR, Neutrophil function disorders: pathophysiology, prevention, and therapy, J Pediatr, 1991;119:343-54
22. Champi C, Primary immunodeficiency disorders in children: prompt diagnosis can lead to lifesaving treatment, J Pediatr Health Care, 2002;16:16-21
23. Slatter MA, Gennery AR, Clinical immunology review series: an approach to the patient with recurrent infections in childhood, Clin Exp Immunol, 2008;152:389-96
24. Evans N, Immature immune system and risk of infection in newborn infants, 2010. Available at: www.helium.com/items/1847365-immature-immune-system-and-risk-of-infection-innewborn-infants (accessed 9 October 2012).
25. de Martino M, Balloti S, The child with recurrent respiratory infections: normal or not?, Pediatr Allergy Immunol, 2007;18(Suppl 18):13-8
26. Li Volti G, Malaponte G, Bevelacqua V, et al., Persistent high plasma levels of interleukins 18 and 4 in children with recurrent infections of the upper respiratory tract, Transplant Proc, 2003;35:2911-5.
27. Don M, Fasoli L, Gregorutti V, et al., Recurrent respiratory infections and phagocytosis in childhood, Pediatr Int, 2007;49:40-7.
28. Bloomberg GR, The influence of environment, as represented by diet and air pollution, upon incidence and prevalence of wheezing illnesses in young children, Curr Opin Allergy Clin Immunol, 2011;11:144-9
29. Uhari M, Mäntysaari K, Niemelä M, A meta-analytic review of the risk factors for acute otitis media, Clin Infect Dis, 1996;22:1079-83
30. Pickering LK, Granoff DM, Erickson JR, et al., Modulation of the immune system by human milk and infant formula containing nucleotides, Pediatrics, 1998;101:242-9.
31. Bousquet J, Fiocchi A, Prevention of recurrent respiratory tract infections in children using a ribosomal immunotherapeutic agent: a clinical review, Paediatr Drugs, 2006;8:235-43
32. Schaad UB, Prevention of paediatric respiratory tract infections: emphasis on the role of OM-85, Eur Respir Rev, 2005;14:74-7
33. Klein JO, Nonimmune strategies for prevention of otitis media, Pediatr Infect Dis J, 2000;19:S89-92
34. Graham NM, The epidemiology of acute respiratory infections in children and adults: a global perspective, Epidemiol Rev, 1990;12:149-78
35. Teele DW, Klein JO, Rosner B, Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study, J Infect Dis, 1989;160:83-94
36. Brook I, Gober AE, Dynamics of nasopharyngitis in children, Otolaryngol Head Neck Surg, 2000;122:696-700
37. Wilson R, Bacteria, antibiotics and COPD, Eur Respir J, 2001;17:995-1007
38. Bacharier LB, Guilbert TW, Diagnosis and management of early asthma in preschool-aged children, J Allergy Clin Immunol, 2012;130(2):287-96
39. Shaheen SO, Barker DJ, Shiell AW, et al., The relationship between pneumonia in early childhood and impaired lung function in late adult life, Am J Respir Crit Care Med, 1994;149:616-9.
40. McCutcheon H, Fitzgerald M, The public health problem of acute respiratory illness in childcare, J Clin Nurs, 2001;10:305-10
41. Banz K, Thomas AM, Olivieri D, Economic evaluation of ribosomal immunotherapy in patients with chronic ear, nose and throat and respiratory tract infections: results for Italy, BioDrugs, 1998;10:385-96
42. Leder K, Sinclair MI, Mitakakis TZ, et al., A community-based study of respiratory episodes in Melbourne, Aust N Z J Public Health, 2003;27:399-404.
43. Lambert SB, O'Grady KF, Gabriel SH, Nolan TM, Respiratory illness during winter: a cohort study of urban children from temperate Australia, J Paediatr Child Health, 2005;41:125-9
44. Lambert S, O'Grady KA, Gabriel S, et al., The cost of seasonal respiratory illnesses in Australian children: the dominance of patient and family costs and implications for vaccine use, Commun Dis Intell, 2004;28:510-6.
45. Felmingham D, Feldman C, Hryniewicz W, et al., Surveillance of resistance in bacteria causing community-acquired respiratory tract infections, Clin Microbiol Infect, 2002;8 Suppl 2:12-42.
46. International Consensus Report on the diagnosis and management of rhinitis. International Rhinitis Management Working Group, Allergy, 1994;49:1-34.
47. Hoberman A, Marchant CD, Kaplan SL, Feldman S, Treatment of acute otitis media consensus recommendations, Clin Pediatr (Phila), 2002;41:373-90
48. Peterson LR, Squeezing the antibiotic balloon: the impact of antimicrobial classes on emerging resistance, Clin Microbiol Infect, 2005;11 Suppl 5:4-16
49. Gillis LM, White HD, Whitehurst A, Sullivan DC, Vancomycintolerance among clinical isolates of Streptococcus pneumoniae in Mississippi during 1999-2001, Am J Med Sci, 2005;330:65-8
50. Akins RL, Haase KK, Gram-positive resistance: pathogens, implications, and treatment options: insights from the Society of Infectious Diseases Pharmacists, Pharmacotherapy, 2005;25:1001-10
51. Jacobs RF, Judicious use of antibiotics for common pediatric respiratory infections, Pediatr Infect Dis J, 2000;19:938-43
52. Riboldi P, Gerosa M, Meroni PL, Pidotimod: a reappraisal, Int J Immunopathol Pharmacol, 2009;22:255-62
53. Bosisio D, Salogni L, Nowak N, et al., OM-85 shapes dendritic cell activation into a 'pre-alert' phenotype, Eur Respir J, 2011;38(Suppl 55):701s.
54. Gutierrez-Tarango MD, Berber A, [In Process Citation], Clin Drug Investig, 1997;13:76-84
55. Razi CH, Harmanci K, Abaci A, et al., The immunostimulant OM-85 BV prevents wheezing attacks in preschool children, J Allergy Clin Immunol, 2010;126:763-9.
56. Quezada A, Maggi L, Pérez MA, Rodríguez J, Effect of bacterial antigen lysate on IgG and IgA levels in children with recurrent infections and hypogammaglobulinemia, J Investig Allergol Clin Immunol, 1999;9:178-82
57. Karaca NE, Gulez N, Aksu G, et al., Does OM-85 BV prophylaxis trigger autoimmunity in IgA deficient children?, Int Immunopharmacol, 2011;11:1747-51.
58. Schaad UB, Farine JC, Fux T, [Prospective placebo-controlled double-blind study using a bacterial lysate in infections of the respiratory tract and ENT region in children], Helv Paediatr Acta, 1986;41:7-17
59. Jara-Pérez JV, Berber A, Primary prevention of acute respiratory tract infections in children using a bacterial immunostimulant: a double-masked, placebo-controlled clinical trial, Clin Ther, 2000;22:748-59
60. Schaad UB, Mutterlein R, Goffin H, BV-Child Study Group, Immunostimulation with OM-85 in children with recurrent infections of the upper respiratory tract: a double-blind, placebo-controlled multicenter study, Chest, 2002;122:2042-9
61. Zagar S, Löfler-Badzek D, Broncho-Vaxom in children with rhinosinusitis: a double-blind clinical trial, ORL J Otorhinolaryngol Relat Spec, 1988;50:397-404
62. Del-Rio-Navarro BE, Luis Sienra-Monge JJ, Berber A, et al., Use of OM-85 BV in children suffering from recurrent respiratory tract infections and subnormal IgG subclass levels, Allergol Immunopathol (Madr), 2003;31:7-13.
63. Gutiérrez-Tarango MD, Berber A, Safety and efficacy of two courses of OM-85 BV in the prevention of respiratory tract infections in children during 12 months, Chest, 2001;119:1742-8